Neogen (NEOG) EBITDA Margin (QoQ) (2010 - 2026)
Neogen (NEOG) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.32 Bn | 196.72 Bn | 7.27 Bn |
| 2 | Stryker | 126.69 Bn | 123.22 Bn | 4.50 Bn |
| 3 | Medtronic | 119.38 Bn | 110.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.54 Bn | 74.00 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.77 Bn | 47.52 Bn | 1.35 Bn |
| 6 | Dexcom | 34.82 Bn | 32.87 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.86 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn |
| 10 | Neogen | 2.56 Bn | 2.37 Bn | 107.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 294.00 |
| Feb 28, 2026 | 83.00 |
| Nov 30, 2025 | 530.00 |
| Aug 31, 2025 | 26,340.00 |
| May 31, 2025 | -27,353.00 |
| Feb 28, 2025 | 20,027.00 |
| Nov 30, 2024 | -19,886.00 |
| Aug 31, 2024 | -447.00 |
| May 31, 2024 | 25.00 |
| Feb 29, 2024 | -104.00 |
| Nov 30, 2023 | -206.00 |
| Aug 31, 2023 | -133.00 |
| May 31, 2023 | 250.00 |
| Feb 28, 2023 | 1,051.00 |
| Nov 30, 2022 | -791.00 |
| Aug 31, 2022 | -829.00 |
| May 31, 2022 | 790.00 |
| Feb 28, 2022 | -458.00 |
| Nov 30, 2021 | -739.00 |
| Aug 31, 2021 | 105.00 |